About Themis Medicare Ltd
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products especially in Formulation and API activity.
Founded
1969
CEO
Dinesh S Patel
Employees
2,028
HQ
Mumbai, India
Finished Products
1Sale of Products
₹776.71Cr2Others
₹5.43Cr3Other Operating Revenues
₹5.13CrRaw Materials
1Raw Material consumed
₹160.98Cr2Finished Goods Purchased
₹127.28CrAbout Themis Medicare Ltd
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products especially in Formulation and API activity.
Founded:1969
CEO:Dinesh S Patel
Employees:2,028
HQ:Mumbai, India
Finished Products
1Sale of Products
₹776.71Cr2Others
₹5.43Cr3Other Operating Revenues
₹5.13CrRaw Materials
1Raw Material consumed
₹160.98Cr2Finished Goods Purchased
₹127.28CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹148
52W Low
₹65
Volume107.96K
Avg VolumeN/A
Beta1.38
Dividend Yield0.40%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
28.59x
Valuation
P/B Ratio
3.13x
Valuation
EPS
₹4.34
Valuation
Dividend Yield
0.40%
Valuation
ROE
0.42%
Profitability
ROCE
2.70%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
81.9%
International
18.1%
India81.9%
Outside India18.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
G
Gedeon Richter Ltd
Hungary
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.25x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.